Evidence map›Paper›PMID 28606561›Full record

ArticleDevelopmental biology2017

STAT5 deletion in macrophages alters ductal elongation and branching during mammary gland development.

Nicholas J Brady, Michael A Farrar, Kathryn L Schwertfeger

Open access · hybridAbstract read
In one paragraph

Article in Developmental biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Mechanisms of Regulation of Cell Fate in Breast Development and Cancer.Advances in experimental medicine and biology · 2025
    Review
  3. Article
  4. Immune Cell Contribution to Mammary Gland Development.Journal of mammary gland biology and neoplasia · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Regulation of myeloid-cell activation.Current opinion in immunology · 2021
    Review
  9. Article
  10. Article
  11. Regulation of aromatase in cancer.Molecular and cellular biochemistry · 2021
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nicholas J BradyMicrobiology, Immunology and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, MN 55455, United States.
Michael A FarrarDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, United States; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States; Center for Immunology, University of Minnesota, Minneapolis, MN 55455, United States.
Kathryn L SchwertfegerDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, United States; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States; Center for Immunology, University of Minnesota, Minneapolis, MN 55455, United States. Electronic address: schwe251@umn.edu.
University of Minnesota · USUniversity of Minnesota Medical Center · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
TRAINING GRANT IN MICROBIOLOGY/CANCER RESEARCHT32CA009138 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Scott M. Dehm · 1985 to 2026
$11.3M
Contributions of FGFR-Mediated Tumor-Stromal Interactions to Breast Cancer Growth and ProgressionR01CA215052 · NCI · UNIVERSITY OF MINNESOTA · PI Kathryn L Schwertfeger · 2017 to 2026
$3.6M
Inflammation in Breast Cancer Initiation and PromotionR01CA132827 · NCI · UNIVERSITY OF MINNESOTA · PI SCHWERTFEGER, KATHRYN L · 2011 to 2015
$1.5M
(PQB-3) Characterization of the immune response during mammary tumor initiationR21CA184541 · NCI · UNIVERSITY OF MINNESOTA · PI SCHWERTFEGER, KATHRYN L · 2014 to 2015
$364k
NCATS NIH HHS UL1 TR000114NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA132827NCI NIH HHS R01 CA215052NCI NIH HHS R21 CA184541NCI NIH HHS T32 CA009138
6 · The paper itself

Abstract

Macrophages are required for proper mammary gland development and maintaining tissue homeostasis. However, the mechanisms by which macrophages regulate this process remain unclear. Here, we identify STAT5 as an important regulator of macrophage function in the developing mammary gland. Analysis of mammary glands from mice with STAT5-deficient macrophages demonstrates delayed ductal elongation, enhanced ductal branching and increased epithelial proliferation. Further analysis reveals that STAT5 deletion in macrophages leads to enhanced expression of proliferative factors such as Cyp19a1/aromatase and IL-6. Mechanistic studies demonstrate that STAT5 binds directly to the Cyp19a1 promoter in macrophages to suppress gene expression and that loss of STAT5 results in enhanced stromal expression of aromatase. Finally, we demonstrate that STAT5 deletion in macrophages cooperates with oncogenic initiation in mammary epithelium to accelerate the formation of estrogen receptor (ER)-positive hyperplasias. These studies establish the importance of STAT5 in macrophages during ductal morphogenesis in the mammary gland and demonstrate that altering STAT5 function in macrophages can affect the development of tissue-specific disease.

Indexed as

AnimalsAromataseCell LineCell ProliferationEnzyme ActivationEpithelial CellsFemaleGene Expression RegulationInterleukin-6Macrophage ActivationMacrophagesMammary Glands, AnimalMiceMice, TransgenicMorphogenesisOrganogenesisAromataseFgfr1 protein, mouseInterleukin-6interleukin-6, mouseReceptor, Fibroblast Growth Factor, Type 1Receptors, EstrogenStat5a protein, mouseStat5b protein, mouseSTAT5 Transcription FactorAromataseDuctal morphogenesisEstrogenMacrophageMammary glandSTAT5

Identifiers

PMID28606561
PMCPMC5621646
OpenAlexW2624409327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.